NCT05034367View on ClinicalTrials.gov

Reference Ranges for the Cough Responsiveness to Inhaled Mannitol

NACompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

January 17, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Cough
Interventions
DIAGNOSTIC_TEST

Mannitol challenge

Inhalation challenge with dry powder of mannitol with a maximal cumulative dose of 635 mg

Trial Locations (2)

2305

John Hunter Hospital, Newcastle

70029

Kuopio University Hospital, Kuopio

All Listed Sponsors
collaborator

John Hunter Hospital

OTHER_GOV

lead

Kuopio University Hospital

OTHER